Evidence map›Paper›PMID 36083887›Full record

ArticlePloS one2022

Mathematical modeling and optimizing the in vitro shoot proliferation of wallflower using multilayer perceptron non-dominated sorting genetic algorithm-II (MLP-NSGAII).

Fazilat Fakhrzad, Abolfazl Jowkar, Javad Hosseinzadeh

Abstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Prediction ofHeliyon · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fazilat FakhrzadDepartment of Horticultural Science, College of Agriculture, Shiraz University, Shiraz, Iran.ORCID 0000-0001-5627-8771
Abolfazl JowkarDepartment of Horticultural Science, College of Agriculture, Shiraz University, Shiraz, Iran.ORCID 0000-0002-0673-8079
Javad HosseinzadehDepartment of Electrical Engineering, Amirkabir University of Technology, Tehran, Iran.ORCID 0000-0002-8892-3621

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel computational methods such as artificial neural networks (ANNs) can facilitate modeling and predicting results of tissue culture experiments and thereby decrease the number of experimental treatments and combinations. The objective of the current study is modeling and predicting in vitro shoot proliferation of Erysimum cheiri (L.) Crantz, which is an important bedding flower and medicinal plant. Its micropropagation has not been investigated before and as a case study multilayer perceptron- non-dominated sorting genetic algorithm-II (MLP-NSGAII) can be applied. MLP was used for modeling three outputs including shoots number (SN), shoots length (SL), and callus weight (CW) based on four variables including 6-benzylaminopurine (BAP), kinetin (Kin), 1-naphthalene acetic acid (NAA) and gibberellic acid (GA3). The R2 correlation values of 0.84, 0.99 and 0.93 between experimental and predicted data were obtained for SN, SL, and CW, respectively. These results proved the high accuracy of MLP model. Afterwards the model connected to Non-dominated Sorting Genetic Algorithm-II (NSGA-II) was used to optimize input variables for obtaining the best predicted outputs. The results of sensitivity analysis indicated that SN and CW were more sensitive to BA, followed by Kin, NAA and GA. For SL, more sensitivity was obtained for GA3 than NAA. The validation experiment indicated that the difference between the validation data and MLP-NSGAII predicted data were negligible. Generally, MLP-NSGAII can be considered as a powerful method for modeling and optimizing in vitro studies.

Indexed as

ErysimumCell ProliferationKinetinModels, TheoreticalNeural Networks, ComputerKinetin

Identifiers

PMID36083887
PMCPMC9462766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.